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Health workersHealth workers represent an important target group for seasonal influenza vaccination because of their
increased risk of infection as well as the risk of transmitting infection to vulnerable patients in the health
care setting. Moreover, seasonal vaccination of health workers contributes to pandemic preparedness.
However, many countries, especially in Africa and Asia, do not have policies for health worker influenza
vaccination. In countries where such policies exist, vaccination coverage is often low. The World Health
Organization (WHO) is developing a manual to guide the introduction of seasonal influenza vaccination
of health workers. An Independent External Advisory Group (IEAG) that is advising WHO on the content
of the manual met to discuss issues that are relevant and often unique to health worker vaccination. This
meeting report summarizes the main issues that were discussed and the outcomes of the discussion. The
issues include policy considerations, including the evidence in support of health worker vaccination; cat-
egorization and prioritization of health workers; the choice of vaccination strategy; its integration into
broader health worker vaccination and occupational health policies; planning and management of vacci-
nation, particularly the approaches for communication and demand generation; and the challenges with
monitoring and evaluation of health worker vaccination, especially in low and middle-income countries.
 2019 World Health Organization; licensee Elsevier. This is an open access article under the CCBY-NC-ND
IGO license (http://creativecommons.org/licenses/by-nc-nd/3.0/igo/).1. Introduction
Health workers are at increased risk of influenza virus infection,
which may be variable depending on their occupation or setting
[1]. The World Health Organization (WHO) considers health work-
ers to be an important priority group for influenza vaccination, not
only to protect themselves and maintain essential health services
during influenza epidemics, but also to reduce the spread of influ-
enza to vulnerable patient groups with whom they may come into
contact [2]. Health workers who have themselves been vaccinated
are also more knowledgeable about vaccination and likely to pro-
mote vaccination to other target populations [3–5]. In addition,protecting health workers from seasonal influenza through vacci-
nation can contribute to maintaining health-care services during
influenza epidemics and should thus be considered part of a
broader infection control policy for health-care facilities [2].
Finally, seasonal vaccination of health workers would lead to the
establishment of a platform for rapidly vaccinating health workers
in the event of an influenza pandemic or even of other epidemics,
e.g. Ebola, thereby protecting health services during this period
[6,7].
The WHO Global Influenza Strategy 2019–2030 provides a
framework for WHO, its Member States and partners to approach
influenza holistically through tailored national programmes – from
surveillance to disease prevention and control – with the goal of
strengthening seasonal prevention and control and preparedness
for future pandemics. It highlights the achievements made toward
this goal since 2011 and re-focuses the strategic way forward
toward filling two urgent gaps – the need for better tools to
prevent and control influenza and the need for strong national
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Four strategic objectives and ten priorities form the basis for
implementation of the strategy. Objective three explicitly high-
lights expanding prevention and control policies and programmes
to improve health and serve the vulnerable through support to
countries to develop and implement national, seasonal immuniza-
tion policies for health workers and other high-risk groups.
The global adoption of the policy for seasonal vaccination has
been slow. In 2017, 119 of 194WHOMember States reported using
influenza vaccine. Of these, 96 reported having a national influenza
vaccination policy in place and an additional 23 included seasonal
influenza vaccine in their schedules without a national policy. A
national vaccination policy targeting health workers was in place
in 102 countries. Coverage of influenza vaccination in health work-
ers varies widely and is reported to be low in most countries where
data are available. Generally, use of influenza vaccine is very low in
the WHO African and Southeast Asian Regions [9,10]. In the Euro-
pean Region, 26 countries reported data on vaccine coverage in
health workers, which ranged from 3% to 99%, with only three
countries reporting coverage >75% [11]. A systematic review
through compulsory reporting from all hospitals in the United
Kingdom showed an uptake of 69% for the 2017–18 season [12].
Data from surveys in other regions reflect a similar range, though
an internet survey of over 2000 health workers in the United States
showed coverage of 78% during the 2017–18 season, with a higher
uptake (95%) among those who were required by their employers
to be vaccinated [13].
In 2018, as part of the coordinatedWHO effort toward strength-
ening influenza programmes in its Member States, an Independent
Expert Advisory Group (IEAG) was established to inform the devel-
opment of an Introduction Manual for Influenza Vaccination of Health
Workers. The manual is a decision-making aid for national policy-
making bodies and programme managers of immunization, occu-
pational health or influenza vaccine programmes. It serves as a
resource and catalogue of available tools to help country officials
decide on, plan, implement and monitor health worker influenza
vaccination policies, with guidance on how to achieve optimal vac-
cination coverage. It articulates general principles and key consid-
erations to support three areas: policy development; planning and
management; and monitoring and evaluation.
The IEAG met on January 16–17, 2019 in Berlin to review the
contents of the manual, share experiences, and discuss important
aspects of the manual, taking into consideration the varying con-
texts, diverse priorities and capacities in countries around the
world. This report briefly summarizes the discussions at this
meeting.2. The IEAG perspective – challenges and potential solutions
In introducing any new vaccine into a national immunization
programme, several factors need to be considered, from making
an informed decision to planning, implementing and monitoring
vaccine introduction. These issues are generically covered in a
WHO guidance document on vaccine introduction [14]. At this
meeting, the IEAG discussions focused on a few selected issues that
specifically relate to influenza vaccination of health workers,
namely: (a) policy development; (b) planning and management
of vaccination, in particular communication approaches and mea-
sures to increase demand; and (c) the challenges with monitoring
and evaluation of health worker vaccination.3. Policy development
The issues that were discussed on the development of policies
for seasonal influenza vaccination included the evidence in supportof health workers vaccination, categorization and prioritization of
health workers to be targeted for vaccination, the choice of manda-
tory versus voluntary vaccination policies and its integration into
the broader health worker immunization and occupational health
policies.3.1. Evidence to support health worker vaccination
While the existing WHO recommendations on seasonal influ-
enza vaccination are unequivocal about vaccination of health
workers, there is an ongoing debate about the strength of the evi-
dence to justify health worker vaccination in the first place [15].
The IEAG recognized the challenges in conducting studies to gener-
ate high-quality, conclusive evidence in support of health worker
vaccination across all health worker categories. They acknowl-
edged that risk of infection among health workers may vary
between health worker categories and the transmission of infec-
tion from health workers to patients may also vary between differ-
ent health care settings and patient types. The impact of
vaccination would be influenced by several factors, including the
risk of infection, rates of transmission in different health care set-
tings, and the varying effectiveness of the vaccine in different sea-
sons. Some of these factors may underlie the conflicting results
observed in different studies. The IEAG noted that even though a
recent Rapid Evidence Appraisal review commissioned by WHO
(published in Vaccine: X [58]) indicates that health workers are
at an increased risk of influenza infection compared to the general
population (1), the evidence is stronger for asymptomatic infection
rather than symptomatic infection [16]. However, asymptomatic
infection in health workers heightens concerns about the risk of
nosocomial transmission from health workers. Several studies
have documented that health workers continue to work with influ-
enza like illnesses (ILI), which has been referred to as ‘‘presen-
teeism” [17–19], with one study reporting subsequent
nosocomial transmission in an oncology unit [20]. Studies have
also shown that influenza vaccination reduces absenteeism and
the incidence of laboratory-confirmed influenza among health
workers [21] and reduces patient mortality and other non-
specific indicators [22,23].
Despite the lack of high-quality evidence for some areas and
conflicting findings in the published literature, the IEAG was com-
fortable that there was enough evidence in support of the existing
WHO recommendation. However, they noted that evidence will be
reconsidered in the coming year by the WHO Strategic Advisory
Group of Experts (SAGE) on Immunization and recommendations
revised, if necessary.3.2. Categorization and prioritization of health workers for vaccination
Ideally, all health workers should be vaccinated. However,
financing and vaccine supply may not allow this, especially in
low- and middle-income countries (LMICs) and stratification of
health workers by risk, occupation, or clinical area of work is a real-
istic part of policy development. There is wide variation in the
health worker categories targeted for vaccination and often the
definitions of those categories targeted for vaccination are unclear
or difficult to define [24]. Meeting participants also noted that in
some cases stratification is impractical as health workers may
change risk categories as a result of task-shifting when the health
worker to patient ratio is very low. The IEAG concluded that while
vaccination of all health workers is ideal, this may not always be
feasible. Simplification of the guidance for categorizing and target-
ing health workers for vaccination will be required, especially for
use in LMICs.
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Policy development also involves deciding on the choice of
mandatory or voluntary vaccination policies. Mandatory vaccina-
tion makes vaccination a legal or regulatory requirement, while
allowing some exemptions, e.g. medical contraindications. Volun-
tary vaccination, on the other hand, leaves the choice up to the
individual health worker. There is no WHO or other uniformly
applied definition for mandatory vaccination. Infant or childhood
vaccination programmes that are described as mandatory can vary
widely, especially in terms of the exemptions allowed and the
penalties for non-compliance [25]. No single intervention has been
shown to rapidly and substantially increase health worker vaccina-
tion other than mandatory vaccination. Mandatory vaccination of
health workers has resulted in close to 100% uptake in institutions
in the United States where it has been applied [26–29]. However,
mandatory vaccination has been difficult to implement in some
countries because of ethical or legal considerations. Several experts
have argued that mandatory immunization policies should be
implemented against vaccine-preventable diseases that can be
transmitted and cause significant morbidity to patients, as part of
the principles of the professional ethics of health care providers
[26,30–33]. Ensuring conditions for patient safety by minimizing
the potential for transmission of communicable diseases in health
care settings may represent the minimum ethical standards in
health care facilities [31].
Mandatory vaccination can be part of the national policy or
implemented at individual health facilities as part of institutional
policies. In establishing a policy of mandatory vaccination, the jus-
tification for its use must be clearly communicated to the employ-
ees; state which employees it applies to; include the process and
exemptions; advise on enforcement and consequences; and
describe contingency plans, e.g. in case of vaccine shortage. Fur-
thermore, liability issues will need to be addressed and considera-
tion given to providing compensation in case of adverse events
following immunization, which may not always be possible in
resource-limited settings.
The alternative is voluntary vaccination, which also requires
resources to ensure optimum uptake of vaccination, including a
robust communications strategy, convenient access to vaccination
(ideally free of charge), or the development and implementation of
‘‘soft mandates” like active declination, the obligation to wear
masks, or reassignment of health workers to other lower risk areas
if they decline vaccination.
3.4. Integration with broader health worker immunization and
occupational health policies
Health workers are at increased risk for several infectious dis-
eases, which they can also transmit to vulnerable patient groups
in the health care setting. Furthermore, health workers often con-
tinue to work when they have infections, placing their patients and
colleagues at risk. WHO currently recommends the use of ten vac-
cines in health workers [34]. While influenza is unique in that it
requires annual vaccination, policy recommendations for influenza
should be part of a broader policy on vaccination of health workers.
This would bring about uniformity in how vaccination policies are
applied, including mandatory vaccination policies. Vaccination
policies should also be part of national occupational safety and
health policies to avoid any potential conflicts between immuniza-
tion and occupational health policies and allow access to free vac-
cination as mandated by the Occupational Safety and Health
Convention of 1981 (Article 21) [35]. An integrated policy would
also enable a more comprehensive approach to the control of influ-
enza in the health care setting, where immunization is one of sev-
eral infection control measures.4. Planning and management
Factors which contribute to low uptake of influenza vaccination
in health workers are multi-factorial, have been extensively stud-
ied [36] and are the focus of numerous public health program
efforts to improve vaccine uptake [37]. Attitudes and behaviours
towards influenza vaccination among health workers may be
heterogenous and may also vary across health worker categories
[38,39].4.1. Formative research
Formative research can help to better understand the local fac-
tors affecting uptake of vaccination and to take the findings into
consideration in planning for vaccine introduction [40,41]. It may
be either quantitative or qualitative, with the former being used
to describe and quantify the main determinants of vaccine uptake
and the latter being used to obtain more in-depth understanding of
the complex issues underlying vaccine uptake. While formative
research will inform the planning process, it may be time and
resource intensive. The IEAG noted that if such research is not
well-designed and executed, there is a risk of obtaining ambiguous
results. The consensus was that while formative research is likely
to be informative and would assist in the planning process, the lack
of formative research should not delay the introduction of health
worker vaccination. Available published information, supple-
mented by quantitative data from rapid surveys, could be used to
inform the planning process in the absence of locally conducted
formative research.4.2. Communication strategy
Communication strategies are pivotal to the success of any vac-
cination approach, voluntary or mandatory, and a multi-
dimensional, sustained, and evolving effort is required to ensure
adequate vaccine uptake [42]. Personal beliefs, attitudes and per-
ceptions about vaccination, rather than official recommendations
often guide the actions of both those responsible for delivery of
vaccination and the recipients [43,44]. This holds true also for
health workers.
The IEAG discussed communication strategies, stressed the
importance of developing locally-relevant communications cus-
tomized to the individual health worker group being targeted,
and taking the education levels and cultural context into consider-
ation. However, message framing or how a message is best deliv-
ered is a critical part of communications [36,45], and will benefit
from an understanding of vaccine psychology and cognitive
decision-making [46].
Available evidence shows that there are often misperceptions
about vaccination as well as a gap between knowledge and beha-
viours [46,47]. However, correcting myths about influenza does
not always lead to changes in behaviour, and may even have a neg-
ative effect. For example, one study found that corrective informa-
tion adapted from the Centers for Disease Control and Prevention
(CDC) website significantly reduced belief in the myth that influ-
enza vaccine can cause influenza disease as well as concerns about
its safety. However, the correction also significantly reduced intent
to vaccinate among respondents with high levels of concern about
vaccine side effects - a response that was not observed among
those with low levels of concern. [48]. Thus, simply improving
knowledge about the risks and benefits of vaccination among
health workers may not be enough to achieve optimal vaccination
uptake. Rather a communications effort that is informed by a good
understanding of the perception, motivators and barriers of
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vaccination and as recipients is needed.
Communication methods can include customized mass com-
munications or peer communications and proactive media engage-
ments to avoid negative media coverage. The inclusion of
information on influenza vaccination in the medical, nursing, and
allied health, e.g. physiotherapy, or laboratory sciences curriculum
may serve to instil the culture of vaccination and to ensure the
right information is cultivated from the start.
4.3. Demand generation beyond communication
While effective communications may improve knowledge,
change attitudes and result in an intention to get vaccinated, addi-
tional demand-generation strategies are necessary to convert the
intentions into positive actions. These behavioural-science,
nudge-based interventions can be implemented prior to vaccina-
tion to prime workers for vaccine delivery. They work by creating
an environment that can influence behaviour in a predictable way
without eliminating choice [49], which is a good option to encour-
age uptake when mandatory vaccination is not pursued. They have
proven effective in a variety of healthcare settings [50] and can
narrow the gap between the intention to be vaccinated and the
actual vaccination behaviour. Additionally, these interventions fre-
quently can be implemented for relatively low cost [51], which
makes them particularly relevant in low- and middle-income
countries. Nudge-based interventions include cues-to-action,
which have been shown to be one of the strongest determinants
of uptake [36], or text message reminders to vaccinators and vac-
cine recipients. Standing orders programmes, which authorize
nurses and pharmacists to administer vaccinations according to
an institution- or physician-approved protocol without the need
for a physician’s examination or direct order have also been shown
to improve influenza vaccination rates, especially in long term care
facilities and hospitals [52]. Additionally, front line vaccination
staff responsible for health worker influenza vaccination need to
be trained on the importance of vaccination, safety considerations,
disease-specific data and advised on how to deal with vaccine hesi-
tant health workers.
Additional methods to increase uptake include the use of ‘‘vac-
cination champions”, use of reward incentives for health worker
groups who achieve certain vaccine targets, and the use of seasonal
vaccination mass campaigns that emphasizes a festive atmosphere
while practicing critical pandemic vaccination skills [53].5. Monitoring and evaluation
The discussions on monitoring and evaluation centred on the
complexity and feasibility of monitoring different outcomes,
including what might be the minimum requirements for monitor-
ing health worker vaccination programmes. It was suggested that
all countries should have mechanisms in place to monitor vaccina-
tion coverage and Adverse Events Following Immunization (AEFI)
and conduct at least one post-vaccine introduction programme
evaluation. On the other hand, measurement of vaccine accep-
tance, vaccine effectiveness and impact may not be feasible in all
countries. In addition, the IEAG noted the risk that studies to mea-
sure acceptance, effectiveness or impact, if not well designed and
conducted, could produce misleading results.
5.1. Coverage monitoring
Several approaches for estimating influenza vaccine coverage
among health workers are available. Ideally, coverage assessments
should be done at some point after the influenza season, whencomplete data are available and assessed and adjusted for any dis-
crepancies. It may be necessary and feasible in only a representa-
tive number of settings within a country.
Health facility registers or other administrative data sources
could be used to provide estimates of the target population and
the numbers vaccinated each season to obtain coverage estimates.
Alternatively, annual or periodic surveys in a representative sam-
ple of health workers may be used to estimate coverage. Examples
of using health facility surveys [54] and online systems [55] were
presented at the meeting.5.2. Surveillance of adverse events following immunization
As for any vaccine and target group, a functioning AEFI monitor-
ing system is a basic requirement of immunization programmes,
all the more in view of possible knowledge gaps and mispercep-
tions about influenza vaccine safety among health workers. The
system to monitor and investigate possible AEFI when delivering
influenza vaccine to health workers should ideally be integrated
into existing AEFI surveillance systems in line with national regu-
lations for the monitoring of vaccine safety. By establishing and
enhancing AEFI systems, influenza vaccination can also be used
to further improve the awareness of overall immunization safety
in the health worker community.5.3. Impact monitoring
After an influenza vaccine has been introduced in a population,
additional studies may help in evaluating the impact of the immu-
nization program. Data from vaccine effectiveness studies can be
used to assess whether the objectives of vaccination were being
met. However, studies to demonstrate vaccine effectiveness or
impact are difficult to conduct for influenza, given that influenza
vaccine effectiveness is modest and can vary considerably across
influenza seasons [56]. Studies to evaluate the impact of seasonal
influenza vaccination in health workers can be even more complex,
given the varying risk of infection and transmission to patients
among different categories of health workers. The challenges of
accurately measuring certain outcomes unique to health worker
vaccination, such as absenteeism and rates of nosocomial trans-
mission, were highlighted. The IEAG cautioned that if studies are
not appropriately designed with adequate sampling of different
health worker categories, there is a risk of arriving at misleading
conclusions. Such studies are not required in every country and
should be limited to settings where the resources and capacities
exist to conduct a rigorous assessment.5.4. Post-introduction programme evaluation
National Immunization Program Reviews routinely assess the
use of specific vaccines about every 5 years. However, following a
new vaccine introduction, and in case of the need for change of
current practice, a specific influenza-related Post-Introduction
Evaluation (I-PIE) [57] tool should be used to rapidly identify prob-
lem areas needing correction and to provide valuable lessons for
the continued and improved use of the vaccine. This tool, devel-
oped by CDC and WHO, provides a framework and standardized
questionnaires to evaluate all the processes and programmatic
impact of influenza vaccination, and provides guidance on data
analysis and a template for making recommendations to corrective
action. The tool has been pilot tested in three middle-income coun-
tries, Belarus, Morocco and Thailand, where valuable insights were
gained that allowed for focussed programme improvements. [sub-
mited to Vaccine]
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Seasonal influenza vaccination in health workers is recom-
mended by WHO not only to protect health workers, and to reduce
spread of influenza to vulnerable patient groups but also to main-
tain health-care services during influenza epidemics and to put
needed capacities in place to prepare for a pandemic outbreak.
However, policies for health worker vaccination do not exist in
many countries and where they do exist, vaccination coverage
remains low. WHO is developing a manual to provide guidance
to countries wishing to introduce seasonal influenza vaccination
of health workers. The IEAG advising WHO on the contents of the
manual discussed several difficult issues related to health worker
vaccination to arrive at a consensus on how to deal with them in
advising countries in vaccine implementation. Based on the guid-
ance received, WHO will develop a field test version of the manual,
which will be piloted in a few LMICs settings.Disclaimer
Philipp Lambach works for the World Health Organization. The
authors alone are responsible for the views expressed in this pub-
lication and they do not necessarily represent the decisions, policy
or views of the World Health Organization.
Dr Salah Al Awaidy, Dr Joseph S. Bresee, Dr Thomas Cherian, Dr
Supamit Chunsuttiwat, Dr Daouda Coulibaly, Dr Luzhao Feng, Dr
Rachel Hale, Dr Philipp Lambach, Dr Helena C. Maltezou, Dr Carsten
Mantel, Dr Kelly Moore, Ms. Kathleen Morales, Professor Dr
Jonathan Nguyen-V van- Tam, Dr Saad Omer, declared that they
have no known competing financial interests or personal relation-
ships that could have appeared to influence the work reported in
this paper.
Dr Gregory Poland is the chair of a Safety Evaluation Committee
for novel investigational vaccine trials being conducted by Merck
Research Laboratories. He offers consultative advice on vaccine
development to Merck & Co. Inc., Avianax, Adjuvance, Sanofi Pas-
teur, GlaxoSmithKline, and Emergent Biosolutions. Dr. Poland
holds two patents related to vaccinia and measles peptide
research. These activities have been reviewed by the Mayo Clinic
Conflict of Interest Review Board and are conducted in compliance
with Mayo Clinic Conflict of Interest policies. This research has
been reviewed by the Mayo Clinic Conflict of Interest Review Board
and was conducted in compliance with Mayo Clinic Conflict of
Interest policies.
Interests declared by participants of the aforementioned meet-
ing were reviewed and conditionally approved by the meeting Sec-
retariat before the meeting and publicly disclosed by the chair on
the first day of the meeting (January 16, Berlin).Independent Expert Advisory group (IEAG) for health worker
influenza vaccination
Dr Salah Al Awaidy, Department of Communicable Diseases,
Oman.
Dr Joseph S. Bresee (chair), Centers for Disease Control and
Prevention, Atlanta, Georgia, USA.
Dr Supamit Chunsuttiwat, Division of Communicable Diseases,
Ministry of Public Health, Bangkok, Thailand.
Dr Daouda Coulibaly, CDI, Côte d’Ivoire.
Dr Luzhao Feng, Chinese Center for Disease Control and Preven-
tion, Beijing. China.
Dr Rachel Hale, Cardiff University, Cardiff, United Kingdom.
Dr Helena C. Maltezou, Hellenic Center for Disease Control and
Prevention, Greece.Dr Kelly Moore, Tennessee Immunization Program, Tennessee
Department of Health, USA.
Professor Jonathan Nguyen-Van-Tam, Department of Health &
Social Care, London, UK and University of Nottingham, UK.
Dr Saad Omer, Emory University, Atlanta, USA.
Dr Gregory Poland, Vaccine Research Group, Mayo Clinic and
Foundation, Rochester, Minnesota, USA.
Dr Sabine Wicker, University Hospital, Frankfurt, Germany.
Rosanna Lagos, Hospital De Niños Roberto Del Río  Centro para
Vacunas en Desarrollo.
Chile (not present at meeting) Prof Shabir Madhi, University
of Witswatersrand, South Africa (not present at meeting).Meeting participants
Dr Silvia Bino, Institute of Public Health, Albania.
Birte Bödeker, Robert Koch Institute, Berlin, Germany.
Dr Susan Y. Chu, Centers for Disease Control and Prevention,
USA.
Dr Sara Hamid, Emory University, Atlanta, USA.
Dr Kathryn Lafond, Centers for Disease Control and Prevention,
USA.
Julia Neufeind, Robert Koch Institute, Berlin, Germany.
Dr Susan Wang, Centers for Disease Control and Prevention,
USA.WHO Regional Offices’ representative
Ms Phionah Lynn Atuhebwe, African Regional Office, Brazzav-
ille, Republic of Congo.
Dr Philip Gould, South East Asia Regional Office, New Delhi,
India.
Dr James Heffelfinger, Western Pacific Regional Office, Manila,
Philippines.
Ms Pernille Jorgensen, European Regional Office, Copenhagen,
Denmark.
Ms Liudmila Mosina, European Regional Office, Copenhagen,
Denmark.
Ms Alba Maria Ropero-Alvarez, Regional Office of the Americas,
Washington DC, USA.
Dr Hassan Quamrul, Regional Office of the Eastern Mediter-
ranean, Cairo; Egypt.WHO Secretariat
Dr. Shalini Desai, Immunization, Vaccines and Biologicals,
World Health Organization, Geneva, Switzerland.
Ms Rola Egloff, Initiative for Vaccine Research, World Health
Organization, Geneva, Switzerland.
Shoshanna Goldin, Influenza Preparedness and Response, World
Health Organization, Geneva, Switzerland.
Dr Ivan Ivanov, Public Health, Environment and Social Determi-
nants, World Health Organization, Geneva, Switzerland.
Dr Melanie Marti, SAGE Secretariat, Immunization, Vaccines
and Biologicals, World Health Organization, Geneva, Switzerland.
Dr Ann Moen, Chief, Influenza Preparedness and Response,
World Health Organization, Geneva, Switzerland.
Mr Marc Perut, Initiative for Vaccine Research, World Health
Organization, Geneva, Switzerland.
Ms Claudia Steulet, Immunization, Vaccines and Biologicals,
World Health Organization, Geneva, Switzerland.
6260 T. Cherian et al. / Vaccine 37 (2019) 6255–6261Consultant
Ms Kathleen Morales, Sierra Strategy Group, Evian les Baines,
France.Funding
This study was funded by a grant from the World Health Orga-
nization’s Initiative for Vaccine Research. The authors would like to
acknowledge the contributions of the Centers for Disease Control
and Prevention (CDC), which provides financial support to the
World Health Organization Initiative for Vaccine Research
(U50CK000431).Acknowledgements
The authors would like to acknowledge the contributions of the
additional participants to the meeting and WHO staff providing
additional inputs:References
[1] Lietz J, Westermann C, Nienhaus A, Schablon A. The occupational risk of
influenza A (H1N1) infection among healthcare personnel during the 2009
pandemic: a systematic review and meta-analysis of observational studies.
PLoS ONE 2016;11(8):e0162061.
[2] Vaccines against influenza: WHO position paper November 2012. Weekly
Epidemiological Report. 2012; 87(47):pp. 461–476.
[3] Wilson RJ, Paterson P, Jarrett C, Larson HJ. Understanding factors influencing
vaccination acceptance during pregnancy globally: a literature review. Vaccine
2015;33(47):6420–9.
[4] Yuen CY, Tarrant M. A comprehensive review of influenza and influenza
vaccination during pregnancy. J Perinat Neonatal Nurs 2014;28(4):261–70.
[5] Wiley KE, Massey PD, Cooper SC, Wood NJ, Ho J, Quinn HE, et al. Uptake of
influenza vaccine by pregnant women: a cross-sectional survey. Med J
Australia 2013;198(7):373–5.
[6] Zhang W, Hirve S, Kieny MP. Seasonal vaccines - critical path to pandemic
influenza response. Vaccine 2017;35(6):851–2.
[7] Mihigo R, Torrealba CV, Coninx K, Nshimirimana D, Kieny MP, Carrasco P, et al.
2009 Pandemic influenza A virus subtype H1N1 vaccination in Africa–
successes and challenges. J Infect Dis 2012;206(Suppl 1):S22–8.
[8] Organization WH. Global influenza strategy 2019-2030. World Health
Organization. https://www.who.int/influenza/global_influenza_strategy_
2019_2030/en/ (Accessed 31/03/2019).
[9] Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, Murray GD, et al.
Effects of influenza vaccination of health-care workers on mortality of elderly
people in long-term care: a randomised controlled trial. Lancet 2000;355
(9198):93–7.
[10] WHO/UNICEF. Joint Reporting Form. 2017. https://www.who.int/
immunization/monitoring_surveillance/routine/reporting/en/ (Accessed 31/
0372019).
[11] Jorgensen P, Mereckiene J, Cotter S, Johansen K, Tsolova S, Brown C. How close
are countries of theWHO European Region to achieving the goal of vaccinating
75% of key risk groups against influenza? results from national surveys on
seasonal influenza vaccination programmes, 2008/2009 to 2014/2015. Vaccine
2018;36(4):442–52.
[12] Seasonal influenza vaccine uptake in healthcare workers (HCWs) in England:
winter season 2017 to 2018 London: Public Health England; 2018 [Available
from: https://assets.publishing.service.gov.uk/government/uploads/system/
uploads/attachment_data/file/710531/Seasonal_influenza_vaccine_uptake_
HCWs_winter_season_2017_to_2018.pdf. (Accessed 31/03/2019).
[13] Black CL, Yue X, Ball SW, Fink RV, de Perio MA, Laney AS, et al. Influenza
vaccination coverage among health care personnel - United States, 2017–18
influenza season. MMWR Morb Mortal Wkly Rep 2018;67(38):1050–4.
[14] Principles and considerations for adding a vaccine to a national immunization
programme: from decision to implementation and monitoring. Geneva: World
Health Organization; 2014. https://www.who.int/immunization/documents/
general/ISBN_978_92_4_15068_92/en/ (Accessed 31/03/2019).
[15] De Serres G, Skowronski DM, Ward BJ, Gardam M, Lemieux C, Yassi A, et al.
Influenza vaccination of healthcare workers: critical analysis of the evidence
for patient benefit underpinning policies of enforcement. PLoS ONE 2017;12
(1):e0163586.
[16] Kuster SP, Shah PS, Coleman BL, Lam PP, Tong A, Wormsbecker A, et al.
Incidence of influenza in healthy adults and healthcare workers: a systematic
review and meta-analysis. PLoS ONE 2011;6(10):e26239.
[17] Chiu S, Black CL, Yue X, Greby SM, Laney AS, Campbell AP, et al. Working with
influenza-like illness: presenteeism among US health care personnel during
the 2014–2015 influenza season. Am J Infect Control 2017;45(11):1254–8.[18] Mossad SB, Deshpande A, Schramm S, Liu X, Rothberg MB. Working despite
having influenza-like illness: results of an anonymous survey of healthcare
providers who care for transplant recipients. Infect Control Hosp Epidemiol
2017;38(8):966–9.
[19] Rebmann T, Turner JA, Kunerth AK. Presenteeism attitudes and behavior
among Missouri kindergarten to twelfth grade (K-12) school nurses. J Sch Nurs
2016;32(6):407–15.
[20] Wilson KE, Wood SM, Schaecher KE, Cromwell KB, Godich J, Knapp MH, et al.
Nosocomial outbreak of influenza A H3N2 in an inpatient oncology unit
related to health care workers presenting to work while ill. Am J Infect Control
2019. https://doi.org/10.1016/j.ajic.2018.10.024.
[21] Imai C, Toizumi M, Hall L, Lambert S, Halton K, Merollini K. A systematic
review and meta-analysis of the direct epidemiological and economic effects
of seasonal influenza vaccination on healthcare workers. PLoS ONE 2018;13
(6):e0198685.
[22] Amodio E, Restivo V, Firenze A, Mammina C, Tramuto F, Vitale F. Can influenza
vaccination coverage among healthcare workers influence the risk of
nosocomial influenza-like illness in hospitalized patients?. J Hosp Infect
2014;86(3):182–7.
[23] Ahmed F, Lindley MC, Allred N, Weinbaum CM, Grohskopf L. Effect of influenza
vaccination of healthcare personnel on morbidity and mortality among
patients: systematic review and grading of evidence. Clin Infect Dis 2014;58
(1):50–7.
[24] Ropero-Alvarez AM, El Omeiri N, Kurtis HJ, Danovaro-Holliday MC, Ruiz-Matus
C. Influenza vaccination in the Americas: progress and challenges after the
2009 A(H1N1) influenza pandemic. Hum Vaccin Immunother 2016;12
(8):2206–14.
[25] MacDonald NE, Harmon S, Dube E, Steenbeek A, Crowcroft N, Opel DJ, et al.
Mandatory infant & childhood immunization: rationales, issues and
knowledge gaps. Vaccine 2018;36(39):5811–8.
[26] Maltezou HC, Poland GA. Immunization of Health-Care Providers: Necessity
and Public Health Policies. Healthcare (Basel). 2016 Aug 1; 4(3). pii:
healthcare4030047. doi: 10.3390/healthcare4030047.
[27] Maltezou HC, Poland GA. Immunization of healthcare providers: a critical step
toward patient safety. Vaccine 2014;32(38):4813. https://doi.org/10.1016/
j.vaccine.2014.05.046. Epub 2014 May 23.
[28] Maltezou HC, Poland GA. Vaccination policies for healthcare workers in
Europe. Vaccine 2014;32(38):4876–80.
[29] Pitts SI, Maruthur NM, Millar KR, Perl TM, Segal J. A systematic review of
mandatory influenza vaccination in healthcare personnel. Am J Prev Med
2014;47(3):330–40.
[30] Ottenberg AL, Wu JT, Poland GA, Jacobson RM, Koenig BA, Tilburt JC.
Vaccinating health care workers against influenza: the ethical and legal
rationale for a mandate. Am J Public Health 2011;101(2):212–6.
[31] Poland GA, Jacobson RM, Wicker S. Mandating influenza vaccination of health
care workers: a patient safety, quality of care, and public trust issue. Ann
Respir Med 2011;2(1).
[32] Sullivan SJ, Jacobson R, Poland GA. Mandating influenza vaccination for
healthcare workers. Expert Rev Vacc 2009;8(11):1469–74.
[33] Tilburt JC, Mueller PS, Ottenberg AL, Poland GA, Koenig BA. Facing the
challenges of influenza in healthcare settings: the ethical rationale for
mandatory seasonal influenza vaccination and its implications for future
pandemics. Vaccine 2008;26(Suppl 4):D27–30.
[34] Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare
workers who work with the elderly: systematic review. Vaccine 2010;29
(2):344–56.
[35] Talbot TR, Babcock H, Caplan AL, Cotton D, Maragakis LL, Poland GA, et al.
Revised SHEA position paper: influenza vaccination of healthcare personnel.
Infect Control Hosp Epidemiol 2010;31(10):987–95.
[36] Schmid P, Rauber D, Betsch C, Lidolt G, Denker ML. Barriers of influenza
vaccination intention and behavior - a systematic review of influenza vaccine
hesitancy, 2005–2016. PLoS ONE 2017;12(1):e0170550.
[37] Butler R, MacDonald NE. Hesitancy SWGoV. Diagnosing the determinants of
vaccine hesitancy in specific subgroups: the guide to tailoring immunization
programmes (TIP). Vaccine 2015;33(34):4176–9.
[38] Maltezou HC, Gargalianos P, Nikolaidis P, Katerelos P, Tedoma N, Maltezos E,
et al. Attitudes towards mandatory vaccination and vaccination coverage
against vaccine-preventable diseases among health-care workers in tertiary-
care hospitals. J Infect 2012;64(3):319–24.
[39] Maltezou HC, Katerelos P, Poufta S, Pavli A, Maragos A, Theodoridou M.
Attitudes toward mandatory occupational vaccinations and vaccination
coverage against vaccine-preventable diseases of health care workers in
primary health care centers. Am J Infect Control 2013;41(1):66–70.
[40] A field guide to qualitative research for new vaccine introduction.
Copenhagen: World Health Organization Regional Office for Europe; 2018.
http://www.euro.who.int/en/health-topics/disease-prevention/vaccines-and-
immunization/publications/2017/field-guide-to-qualitative-research-for-new-
vaccine-introduction (Accessed 31/03/2019).
[41] Tailoring immunization programmes for seasonal influenza (TIP FLU): a guide
for health care workers’ uptake of seasonal influenza vaccination Copenhagen:
World Health Organization Regional Office for Europe; 2015. http://www.
euro.who.int/en/health-topics/disease-prevention/vaccines-and-immunization/
publications/2015/tailoring-immunization-programmes-for-seasonal-influenza-
tip-flu.-understanding-health-care-workers-uptake-of-seasonal-influenza-
vaccination-in-montenegro-a-case-study-for-policy-makers-and-programme-
managers (Accessed 31/03/2019).
T. Cherian et al. / Vaccine 37 (2019) 6255–6261 6261[42] To KW, Lai A, Lee KC, Koh D, Lee SS. Increasing the coverage of influenza
vaccination in healthcare workers: review of challenges and solutions. J Hosp
Infect 2016;94(2):133–42.
[43] Betsch C, Wicker S. Personal attitudes and misconceptions, not official
recommendations guide occupational physicians’ vaccination decisions.
Vaccine 2014;32(35):4478–84.
[44] Rhudy LM, Tucker SJ, Ofstead CL, Poland GA. Personal choice or evidence-based
nursing intervention: nurses’ decision-making about influenza vaccination.
Worldviews Evid Based Nurs 2010;7(2):111–20.
[45] Nyhan B, Reifler J, Richey S, Freed GL. Effective messages in vaccine promotion:
a randomized trial. Pediatrics 2014;133(4):e835–42.
[46] Poland CM, Poland GA. Vaccine education spectrum disorder: the importance
of incorporating psychological and cognitive models into vaccine education.
Vaccine 2011;29(37):6145–8.
[47] Leask J. Target the fence-sitters. Nature 2011;473(7348):443–5.
[48] Nyhan B, Reifler J. Does correcting myths about the flu vaccine work? an
experimental evaluation of the effects of corrective information. Vaccine
2015;33(3):459–64.
[49] Thaler RH, Sunstein CR. Nudge: Improving Decisions About Health, Wealth and
Happiness. New York: Penguin Books; 2009.
[50] Patel MS, Volpp KG, Asch DA. Nudge units to improve the delivery of health
care. N Engl J Med 2018;378(3):214–6.
[51] Patel MS. Nudges for influenza vaccination. Nat Hum Behav 2018;2:720–1.[52] Centers for Disease C, Prevention. Facilitating influenza and pneumococcal
vaccination through standing orders programs. MMWR Morb Mortal Wkly
Rep. 2003; 52(4):pp. 68–69.
[53] Swift MD, Aliyu MH, Byrne DW, Qian K, McGown P, Kinman PO, et al.
Emergency preparedness in the workplace: the Flulapalooza model for mass
vaccination. Am J Public Health 2017;107(S2):S168–76.
[54] Yang JS, Zhang LJ, Feng LZ, Zhao JH, Ma YY, Xu LL. Influenza vaccination and its
influencing factors among clinical staff of the hospitals in 2016–2017 season,
Xining, Qinghai province, China. Zhonghua Liu Xing Bing Xue Za Zhi 2018;39
(8):1066–70.
[55] Bödeker B, Neufeind, J., Bichel, Y., Wichmann, O. OKaPII-Studie: Online-
Befragung von Klinik-personal zur Influenza-Impfung Berlin: Robert Koch
Intitut; [Available from: https://www.rki.de/DE/Content/Infekt/Impfen/
Forschungsprojekte/OKaPII/OKaPII_Inhalt.html].
[56] Evaluation of influenza vaccine effectiveness: a guide to the design and
interpretation of observational studies. Geneva; 2017. https://apps.who.int/
iris/handle/10665/255203.
[57] Influenza vaccine post-introduction evaluation manual and tool. Geneva:
World Health Organization; 2018 https://www.who.int/immunization/
research/development/ipie_influenza_post_introduction_evaluation/en/.
[58] D.C. Jenkin, H. Magoub, K.F. Morales, P. Lambach, J.-S. Nguyen-Van-Tam, A
Rapid Evidence Appraisal of influenza vaccination in health workers: an
important policy in an area of imperfect evidence. Vaccine: X 2 (C), 2019.
